Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small Fiber Neuropathy: A Randomized, Double-Blind Pilot StudyLara R. Heij, Albert Dahan, Marieke Niesters et al.|Molecular Medicine|2012Cited by 110
ARA 290 Improves Symptoms in Patients with Sarcoidosis-Associated Small Nerve Fiber Loss and Increases Corneal Nerve Fiber DensityAlbert Dahan, Michael Brines, Ann Dunne et al.|Molecular Medicine|2013Cited by 94
ARA290, a Peptide Derived from the Tertiary Structure of Erythropoietin, Produces Long-term Relief of Neuropathic PainMaarten Swartjes, Albert Dahan, Aurora M. Morariu et al.|Anesthesiology|2011Cited by 49
ARA 290, a Peptide Derived from the Tertiary Structure of Erythropoietin, Produces Long-Term Relief of Neuropathic Pain Coupled with Suppression of the Spinal Microglia ResponseMaarten Swartjes, Albert Dahan, Monique van Velzen et al.|Molecular Pain|2014Cited by 36
Ketamine Does Not Produce Relief of Neuropathic Pain in Mice Lacking the β-Common Receptor (CD131)Maarten Swartjes, Albert Dahan, Marieke Niesters et al.|PLoS ONE|2013Cited by 20